Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Celltrion Enters Race For Ocrevus Biosimilar, Files Omalizumab In Europe
Roche’s Ocrevus Brought In Sales Of CHF6bn In 2022, Including CHF4.5bn In US
May 02 2023
•
By
Dean Rudge
• Source: Shutterstock
(Panther Media GmbH / Alamy Stock/Alamy Stock Photo)
More from Biosimilars
More from Products
